Clinical Trial Update: Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients [NA]

View source ↗

Summary

Clinical trial update on the NMDA receptor antagonist dextromethorphan assessing its effect on opioid analgesia and tolerance in pediatric ICU patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia Tolerance
• Opioid Tolerance
• Pain

Drugs mentioned

• Dextromethorphan (dextromethorphan)

Snippet

Sponsor: King Abdullah International Medical Research Center | Conditions: Pain, Opioid Tolerance | NA | Status: UNKNOWN